Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 8525679, 11 pages
http://dx.doi.org/10.1155/2016/8525679
Review Article

Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs

1School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore, India
2College of Pharmacy, IPS Academy, Indore, India

Received 30 December 2015; Revised 16 March 2016; Accepted 31 March 2016

Academic Editor: Chiara Riganti

Copyright © 2016 Mayank Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Agrawal, R. Sharma, M. Gupta, and S. P. Vyas, “Is nanotechnology a boon for oral drug delivery?” Drug Discovery Today, vol. 19, no. 10, pp. 1530–1546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. X.-Q. Wang and Q. Zhang, “PH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 82, no. 2, pp. 219–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Li, X. Zhao, Y. Ma, G. Zhai, L. Li, and H. Lou, “Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles,” Journal of Controlled Release, vol. 133, no. 3, pp. 238–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Khadka, J. Ro, H. Kim et al., “Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability,” Asian Journal of Pharmaceutical Sciences, vol. 9, no. 6, pp. 304–316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Hetal, P. Bindesh, and T. Sneha, “A review on techniques for oral bioavailability enhancement of drugs,” International Journal of Pharmaceutical Sciences Review and Research, vol. 4, no. 3, pp. 203–223, 2010. View at Google Scholar · View at Scopus
  6. A. Bernkop-Schnürch, “Nanocarrier systems for oral drug delivery: do we really need them?” European Journal of Pharmaceutical Sciences, vol. 49, no. 2, pp. 272–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Zhang, S. Wang, M. Zhang, and J. Sun, “Nanocarriers for oral drug delivery,” Journal of Drug Targeting, vol. 21, no. 6, pp. 515–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Kumar, A. Sharma, A. Sharma, G. Joshi, and V. Dhillon, “Recent Advances In Ndds (Novel Drug Delivery System) for delivery of anti- hypertensive drugs,” International Journal of Drug Development & Research, vol. 3, no. 1, pp. 252–259, 2011. View at Google Scholar
  9. L. M. Prisant and W. J. Elliott, “Drug delivery systems for treatment of systemic hypertension,” Clinical Pharmacokinetics, vol. 42, no. 11, pp. 931–940, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. M. Prisant, B. Bottini, J. T. DiPiro, and A. A. Carr, “Novel drug-delivery systems for hypertension,” The American Journal of Medicine, vol. 93, no. 2, pp. 45S–55S, 1992. View at Google Scholar · View at Scopus
  11. K. Delmar and H. Bianco-Peled, “Composite chitosan hydrogels for extended release of hydrophobic drugs,” Carbohydrate Polymers, vol. 136, pp. 570–580, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Gupta, D. Bhandari, and A. Sharma, “Recent trends in oral drug delivery: a review,” Recent Patents on Drug Delivery and Formulation, vol. 3, no. 2, pp. 162–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. Patwekar and M. K. Baramade, “Controlled release approach to novel multiparticulate drug delivery system,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 3, pp. 757–763, 2012. View at Google Scholar · View at Scopus
  14. N. Jain, R. Jain, N. Thakur et al., “Nanotechnology: a safe and effective drug delivery system,” Asian Journal of Pharmaceutical and Clinical Research, vol. 3, no. 3, pp. 159–165, 2010. View at Google Scholar · View at Scopus
  15. R. Singh and J. W. Lillard Jr., “Nanoparticle-based targeted drug delivery,” Experimental and Molecular Pathology, vol. 86, no. 3, pp. 215–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Safari and Z. Zarnegar, “Advanced drug delivery systems: nanotechnology of health design—a review,” Journal of Saudi Chemical Society, vol. 18, no. 2, pp. 85–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kalepu and V. Nekkanti, “Insoluble drug delivery strategies: review of recent advances and business prospects,” Acta Pharmaceutica Sinica B, vol. 5, no. 5, pp. 442–453, 2015. View at Publisher · View at Google Scholar
  18. M. Rangasamy and K. G. Parthiban, “Recent advances in novel drug delivery systems,” International Journal of Research in Ayurveda and Pharmacy, vol. 1, no. 2, pp. 316–326, 2010. View at Google Scholar
  19. S. Abeer, “Future medicine: nanomedicine,” Journal International Medical Sciences Academy, vol. 25, no. 3, pp. 187–192, 2012. View at Google Scholar · View at Scopus
  20. A. Gupta and S. Sehrawat, “Bioavailability enhancement of poorly water soluble drugs: a review,” International Journal of Pharmaceutics and Life Sciences, vol. 2, no. 3, pp. 640–650, 2011. View at Google Scholar
  21. S. S. Suri, H. Fenniri, and B. Singh, “Nanotechnology-based drug delivery systems,” Journal of Occupational Medicine and Toxicology, vol. 2, article 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Shaji and V. Bhatia, “Novel lipid carriers for oral delivery of lipophilic drugs,” International Journal of Pharmaceutical Sciences Review and Research, vol. 15, no. 1, pp. 47–53, 2012. View at Google Scholar · View at Scopus
  23. P. Boisseau and B. Loubaton, “Nanomedicine, nanotechnology in medicine,” Journal de Physique Archives, vol. 12, pp. 620–636, 2011. View at Google Scholar
  24. L. Mei, Z. Zhang, L. Zhao et al., “Pharmaceutical nanotechnology for oral delivery of anticancer drugs,” Advanced Drug Delivery Reviews, vol. 65, no. 6, pp. 880–890, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. D. D. Kumar and A. K. Singh, “Dendrimers: a novel carrier system for drug delivery,” Journal of Drug Delivery & Therapeutics, vol. 4, no. 5, pp. 1–6, 2014. View at Google Scholar
  26. B. Gorain, H. Choudhury, A. Kundu et al., “Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats,” Colloids and Surfaces B: Biointerfaces, vol. 115, pp. 286–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. R. Croy and G. S. Kwon, “Polymeric micelles for drug delivery,” Current Pharmaceutical Design, vol. 12, no. 36, pp. 4669–4684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Xu, P. Ling, and T. Zhang, “Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs,” Journal of Drug Delivery, vol. 2013, Article ID 340315, 15 pages, 2013. View at Publisher · View at Google Scholar
  29. S. Tripathy and M. K. Das, “Dendrimers and their applications as novel drug delivery carriers,” Journal of Applied Pharmaceutical Science, vol. 3, no. 9, pp. 142–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. K. Gupta, D. K. Mishra, and S. C. Mahajan, “Preparation and in-vitro evaluation of self emulsifying drug delivery system of antihypertensive drug valsartan,” International Journal of Pharmacy & Life Sciences, vol. 2, no. 3, pp. 633–639, 2011. View at Google Scholar
  31. N. A. Ochekpe, P. O. Olorunfemi, and N. C. Ngwuluka, “Nanotechnology and drug delivery part 2: nanostructures for drug delivery,” Tropical Journal of Pharmaceutical Research, vol. 8, no. 3, pp. 275–287, 2009. View at Google Scholar · View at Scopus
  32. M. F. Francis, M. Cristea, and F. M. Winnik, “Polymeric micelles for oral drug delivery: why and how,” Pure and Applied Chemistry, vol. 76, no. 7-8, pp. 1321–1335, 2004. View at Google Scholar · View at Scopus
  33. V. P. Torchilin, “Targeted polymeric micelles for delivery of poorly soluble drugs,” Cellular and Molecular Life Sciences, vol. 61, no. 19-20, pp. 2549–2559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Raval, N. Joshi, J. Patel, and U. M. Upadhyay, “Enhanced oral bioavailability of olmesartan by using novel solid self emulsifying drug delivery system,” International Journal of Advanced Pharmaceutics, vol. 2, no. 2, pp. 82–92, 2012. View at Google Scholar
  35. P. Satturwar, M. N. Eddine, F. Ravenelle, and J.-C. Leroux, “pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 65, no. 3, pp. 379–387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. B. P. Sahu and M. K. Das, “Nanosuspension for enhancement of oral bioavailability of felodipine,” Applied Nanoscience, vol. 4, no. 2, pp. 189–197, 2014. View at Publisher · View at Google Scholar
  37. H. Ge, Y. Hu, X. Jiang et al., “Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles,” Journal of Pharmaceutical Sciences, vol. 91, no. 6, pp. 1463–1473, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Bharti, U. Nagaich, A. Pal, and N. Gulati, “Mesoporous silica nanoparticles in target drug delivery system: a review,” International Journal of Pharmaceutical Investigation, vol. 5, no. 3, pp. 124–133, 2015. View at Publisher · View at Google Scholar
  39. D. Thakar, P. Bharadia, and V. Pandya, “Enhancement of solubility of poorly water soluble anti hypertensive drug by nanosizing approach,” Journal of Pharmacy and Bioallied Sciences, vol. 4, pp. 40–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. V. J. Mohanraj and Y. Chen, “Nanoparticles—a review,” Tropical Journal of Pharmaceutical Research, vol. 5, no. 1, pp. 561–573, 2006. View at Google Scholar
  41. P. Quan, D. Xia, H. Piao et al., “Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation,” AAPS PharmSciTech, vol. 12, no. 4, pp. 1136–1143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Yu, X. Jie, L. Xu et al., “Recent advances in dendrimer research for cardiovascular diseases,” Biomacromolecules, vol. 16, no. 9, pp. 2588–2598, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Gutiérrez, C. González, A. Maestro, I. Solè, C. M. Pey, and J. Nolla, “Nano-emulsions: new applications and optimization of their preparation,” Current Opinion in Colloid & Interface Science, vol. 13, no. 4, pp. 245–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. I. F. Alexa, M. Ignat, R. F. Popovici, D. Timpu, and E. Popovici, “In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices,” International Journal of Pharmaceutics, vol. 436, no. 1-2, pp. 111–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. I. I. Slowing, J. L. Vivero-Escoto, C.-W. Wu, and V. S.-Y. Lin, “Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers,” Advanced Drug Delivery Reviews, vol. 60, no. 11, pp. 1278–1288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Mukherjee, S. Ray, and R. S. Thakur, “Solid lipid nanoparticles: a modern formulation approach in drug delivery system,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 4, pp. 349–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. K. H. Ramteke, S. A. Joshi, and S. N. Dhole, “Solid lipid nanoparticle: a review,” IOSR Journal of Pharmacy, vol. 2, no. 6, pp. 34–44, 2012. View at Google Scholar
  49. V. K. Venishetty, R. Chede, R. Komuravelli, L. Adepu, R. Sistla, and P. V. Diwan, “Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration,” Colloids and Surfaces B: Biointerfaces, vol. 95, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. V. V. Kumar, D. Chandrasekar, S. Ramakrishna, V. Kishan, Y. M. Rao, and P. V. Diwan, “Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics,” International Journal of Pharmaceutics, vol. 335, no. 1-2, pp. 167–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Ekambaram and A. Abdul Hasan Sathali, “Formulation and evaluation of solid lipid nanoparticles of ramipril,” Journal of Young Pharmacists, vol. 3, no. 3, pp. 216–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Parmar, S. Mandal, K. C. Petkar, L. D. Patel, and K. K. Sawant, “Valsartan loaded solid lipid nanoparticles: development, characterization and in vitro and ex vivo evaluation,” International Journal of Pharmaceutical Sciences and Nanotechnology, vol. 4, no. 3, pp. 1483–1490, 2011. View at Google Scholar
  53. M. Kaur, “Dendrimers: synthesis, its dosage forms and advantage over linear polymers,” Mintage Journal of Pharmaceutical & Medical Sciences, vol. 3, no. 3, pp. 15–19, 2014. View at Google Scholar
  54. P. Kesharwani, K. Jain, and N. K. Jain, “Dendrimer as nanocarrier for drug delivery,” Progress in Polymer Science, vol. 39, no. 2, pp. 268–307, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. B. K. Nanjwade, H. M. Bechra, G. K. Derkar, F. V. Manvi, and V. K. Nanjwade, “Dendrimers: emerging polymers for drug-delivery systems,” European Journal of Pharmaceutical Sciences, vol. 38, no. 3, pp. 185–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. V. R. Babu, V. Mallikarjun, S. R. Nikhat, and G. Srikanth, “Dendrimers: a new carrier system for drug delivery,” International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 1, pp. 1–10, 2010. View at Google Scholar
  57. S. Svenson and A. S. Chauhan, “Dendrimers for enhanced drug solubilization,” Nanomedicine, vol. 3, no. 5, pp. 679–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. S. P. Gautam and A. Verma, “PAMAM dendrimers: novel polymeric nanoarchitectures for solubility enhancement of candesartan cilexetil,” Pharmaceutical Sciences, vol. 1, pp. 1–4, 2012. View at Google Scholar
  59. D. A. Sica, “Pharmacotherapy review: calcium channel blockers,” Journal of Clinical Hypertension, vol. 8, no. 1, pp. 53–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. A. D'Emanuele, R. Jevprasesphant, J. Penny, and D. Attwood, “The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability,” Journal of Controlled Release, vol. 95, no. 3, pp. 447–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Devarakonda, N. Li, and M. M. de Villiers, “Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels,” AAPS PharmSciTech, vol. 6, no. 3, pp. E504–E512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Parveen, R. Misra, and S. K. Sahoo, “Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 2, pp. 147–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Patel, A. Dhingani, K. Garala, M. Raval, and N. Sheth, “Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis,” Powder Technology, vol. 258, pp. 331–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Liu, S. Yu, Z. Zhu et al., “Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation,” International Journal of Pharmaceutics, vol. 475, no. 1-2, pp. 496–503, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Thadkala, C. Sailu, and J. Aukunuru, “Formulation, optimization and evaluation of oral nanosuspension tablets of nebivolol hydrochloride for enhancement of dissoluton rate,” Der Pharmacia Lettre, vol. 7, no. 3, pp. 71–84, 2015. View at Google Scholar · View at Scopus
  66. R. Rajalakshmi, T. Venkataramudu, R. A. Kumar, K. D. Sree, and M. D. Kiranmayi, “Design and characterization of valsartan nano suspension,” International Journal of Pharmacotherapy, vol. 2, no. 2, pp. 70–81, 2012. View at Google Scholar
  67. C. Detroja, S. Chavhan, and K. Sawant, “Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study,” Scientia Pharmaceutica, vol. 79, no. 3, pp. 635–651, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Solans and I. Solé, “Nano-emulsions: formation by low-energy methods,” Current Opinion in Colloid & Interface Science, vol. 17, no. 5, pp. 246–254, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Ghai and V. R. Sinha, “Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective β1-adrenoreceptor blocker Talinolol,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 5, pp. 618–626, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Guan, N. Zhao, Y. Zhai, C. Chu, H. Chen, and T. Zhang, “Pharmacokinetic performance of the nitrendipine intravenous submicron emulsion in rats,” Asian Journal of Pharmaceutical Sciences, vol. 9, no. 6, pp. 330–335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. P. S. Rajinikanth, N. W. Keat, and S. Garg, “Self-nanoemulsifying drug delivery systems of Valsartan: preparation and in-vitro characterization,” International Journal of Drug Delivery, vol. 4, pp. 153–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. S. R. Mudshinge, A. B. Deore, S. Patil, and C. M. Bhalgat, “Nanoparticles: emerging carriers for drug delivery,” Saudi Pharmaceutical Journal, vol. 19, no. 3, pp. 129–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Bamrungsap, Z. Zhao, T. Chen et al., “Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system,” Nanomedicine, vol. 7, no. 8, pp. 1253–1271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. W. H. De Jong and P. J. A. Borm, “Drug delivery and nanoparticles: applications and hazards,” International Journal of Nanomedicine, vol. 3, no. 2, pp. 133–149, 2008. View at Google Scholar · View at Scopus
  75. A. Z. Wilczewska, K. Niemirowicz, K. H. Markiewicz, and H. Car, “Nanoparticles as drug delivery systems,” Pharmacological Reports, vol. 64, no. 5, pp. 1020–1037, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. J. P. Rao and K. E. Geckeler, “Polymer nanoparticles: preparation techniques and size-control parameters,” Progress in Polymer Science, vol. 36, no. 7, pp. 887–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Bharathia, S. C. Prasad, R. L. Eswari et al., “Preparation and in vitro & in vivo characterization of valsartan loaded eudragit nanoparticles,” Der Pharmacia Sinica, vol. 3, no. 5, pp. 516–525, 2012. View at Google Scholar
  78. M. L.-L. Verger, L. Fluckiger, Y.-I. Kim, M. Hoffman, and P. Maincent, “Preparation and characterization of nanoparticles containing an antihypertensive agent,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 46, no. 2, pp. 137–143, 1998. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Zhang, T. Jiang, Q. Zhang, and S. Wang, “Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 1, pp. 17–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. U. Jana, A. K. Mohanty, P. K. Manna, and G. P. Mohanta, “Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100,” Colloids and Surfaces B: Biointerfaces, vol. 113, pp. 269–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. F. Li, A. Zhu, X. Song, and L. Ji, “Novel surfactant for preparation of poly(l-lactic acid) nanoparticles with controllable release profile and cytocompatibility for drug delivery,” Colloids and Surfaces B: Biointerfaces, vol. 115, pp. 377–383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Kumar, M. S. Reddy, R. S. Managuli, and G. Pai, “Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles,” Saudi Pharmaceutical Journal, vol. 23, no. 5, pp. 549–555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. I. Kim, L. Fluckiger, M. Hoffman, I. Lartaud-Idjouadiene, J. Atkinson, and P. Maincent, “The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats,” British Journal of Pharmacology, vol. 120, no. 3, pp. 399–404, 1997. View at Publisher · View at Google Scholar · View at Scopus
  84. X. Zheng, T. Wang, H. Jiang et al., “Incorporation of Carvedilol into PAMAM-functionalized MWNTs as a sustained drug delivery system for enhanced dissolution and drug-loading capacity,” Asian Journal of Pharmaceutical Sciences, vol. 8, no. 5, pp. 278–286, 2013. View at Publisher · View at Google Scholar
  85. B. ShengWong, S. L. Yoong, A. Jagusiak et al., “Carbon nanotubes for delivery of small molecule drugs,” Advanced Drug Delivery Reviews, vol. 65, no. 15, pp. 1964–2015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. S. M. N. Simões, A. R. Figueiras, F. Veiga, A. Concheiro, and C. Alvarez-Lorenzo, “Polymeric micelles for oral drug administration enabling locoregional and systemic treatments,” Expert Opinion on Drug Delivery, vol. 12, no. 2, pp. 297–318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. G. A. Husseini and W. G. Pitt, “Micelles and nanoparticles for ultrasonic drug and gene delivery,” Advanced Drug Delivery Reviews, vol. 60, no. 10, pp. 1137–1152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Arzani, A. Haeri, M. Daeihamed, H. Bakhtiari-Kaboutaraki, and S. Dadashzadeh, “Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge,” International Journal of Nanomedicine, vol. 10, pp. 4797–4813, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. V. B. Junyaprasert and B. Morakul, “Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs,” Asian Journal of Pharmaceutical Sciences, vol. 10, no. 1, pp. 13–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, and K. Amighi, “Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine,” International Journal of Pharmaceutics, vol. 299, no. 1-2, pp. 167–177, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Quan, K. Shi, H. Piao et al., “A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability,” International Journal of Pharmaceutics, vol. 430, no. 1-2, pp. 366–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. Q. Fu, J. Sun, X. Ai et al., “Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption,” International Journal of Pharmaceutics, vol. 448, no. 1, pp. 290–297, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Hildebrand, K. Beyer, R. Neubert, P. Garidel, and A. Blume, “Temperature dependence of the interaction of cholate and deoxycholate with fluid model membranes and their solubilization into mixed micelles,” Colloids and Surfaces B: Biointerfaces, vol. 32, no. 4, pp. 335–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. S. K. R. Bobbala and P. R. Veerareddy, “Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery,” Journal of Liposome Research, vol. 22, no. 4, pp. 285–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. B.-N. Ahn, S.-K. Kim, and C.-K. Shim, “Preparation and evaluation of proliposomes containing propranolol hydrochloride,” Journal of Microencapsulation, vol. 12, no. 4, pp. 363–375, 1995. View at Publisher · View at Google Scholar · View at Scopus
  96. V. Nekkanti and G. Betageri, “Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics,” Drug Development and Industrial Pharmacy, vol. 41, no. 12, pp. 2077–2088, 2015. View at Google Scholar
  97. Y. Zhang, J. Wang, X. Bai, T. Jiang, Q. Zhang, and S. Wang, “Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs,” Molecular Pharmaceutics, vol. 9, no. 3, pp. 505–513, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Hu, Z. Zhi, Q. Zhao et al., “3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol,” Microporous and Mesoporous Materials, vol. 147, no. 1, pp. 94–101, 2012. View at Publisher · View at Google Scholar · View at Scopus